ISSN:

Journal Home

BMC Cancer Q2 Unclaimed

BioMed Central Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

BMC Cancer is a journal indexed in SJR in Genetics and Oncology with an H index of 122. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1507 €. The scope of the journal is focused on cancer. It has an SJR impact factor of 1,186 and it has a best quartile of Q2. It is published in English.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q2) Genetics (Q2) Oncology (Q2)

Price

1507 €

Gold OA

-

Green OA

- €

Non OA

Metrics

1,186

SJR Impact factor

122

H Index

1273

Total Docs (Last Year)

3154

Total Docs (3 years)

46099

Total Refs

10336

Total Cites (3 years)

3096

Citable Docs (3 years)

3,21

Cites/Doc (2 years)

36,21

Ref/Doc

Aims and Scope

Cancer

Other journals with similar parameters

Neurogenetics Q2
Journal of Human Genetics Q2
Gene Expression Q2
Gene Therapy Q2
Journal of Inherited Metabolic Disease Q2

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.